Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Arrhythmias

  Free Subscription


Articles published in J Am Coll Cardiol

Retrieve available abstracts of 295 articles:
HTML format



Single Articles


    May 2020
  1. BOUTJDIR M, Lazzerini PE
    A Novel Peptide/Antibody-Based Antiarrhythmic Approach to Long QT Syndrome and Beyond.
    J Am Coll Cardiol. 2020;75:2153-2155.
    PubMed    


  2. MAGUY A, Kucera JP, Wepfer JP, Forest V, et al
    KCNQ1 Antibodies for Immunotherapy of Long QT Syndrome Type 2.
    J Am Coll Cardiol. 2020;75:2140-2152.
    PubMed     Abstract available


    April 2020
  3. GALLI M, Andreotti F, D'Amario D, Porto I, et al
    Stent Thrombosis With Dual Antithrombotic Therapy in Atrial Fibrillation-ACS/PCI Trials.
    J Am Coll Cardiol. 2020;75:1727-1728.
    PubMed    


  4. MADIAS C, Parzynski CS, Burrows A, Minges KE, et al
    Utilization Effects of the Affordable Care Act on Implantable Cardioverter-Defibrillator Therapy.
    J Am Coll Cardiol. 2020;75:1714-1717.
    PubMed    


  5. CHUNG MK, Refaat M, Shen WK, Kutyifa V, et al
    Atrial Fibrillation: JACC Council Perspectives.
    J Am Coll Cardiol. 2020;75:1689-1713.
    PubMed     Abstract available


  6. RUFF CT
    The Promise of Mobile Health in Managing Atrial Fibrillation.
    J Am Coll Cardiol. 2020;75:1535-1537.
    PubMed    


  7. GUO Y, Lane DA, Wang L, Zhang H, et al
    Mobile Health Technology to Improve Care for Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2020;75:1523-1534.
    PubMed     Abstract available


    March 2020
  8. GUO Y, Liu T, Chen Y, Lip GYH, et al
    Reply: Observations From the Huawei Heart Study Using Photoplethysmography-Based Smart Devices for Atrial Fibrillation Screening.
    J Am Coll Cardiol. 2020;75:1366-1367.
    PubMed    


  9. EERIKAINEN LM, Bonomi AG, Dekker LRC, Aarts RM, et al
    Atrial Fibrillation Episodes Detected Using Photoplethysmography: Do We Know Which Are True?
    J Am Coll Cardiol. 2020;75:1365.
    PubMed    


  10. ANANTHAN K
    The Efficacy and Feasibility of Atrial Fibrillation Screening Using Photoplethysmography-Based Smart Devices.
    J Am Coll Cardiol. 2020;75:1365-1366.
    PubMed    


  11. SEPEHRI SHAMLOO A, Bollmann A, Dagres N, Arya A, et al
    Smart Watch Devices for Atrial Fibrillation Screening: It Has to Start Somewhere.
    J Am Coll Cardiol. 2020;75:1364-1365.
    PubMed    


  12. PONG T, Cyr K, Niesen J, Aparicio-Valenzuela J, et al
    Screening and Prophylactic Amiodarone Reduces Post-Operative Atrial Fibrillation in At-Risk Patients.
    J Am Coll Cardiol. 2020;75:1361-1363.
    PubMed    


  13. POKORNEY SD, Black-Maier E, Hellkamp AS, Friedman DJ, et al
    Oral Anticoagulation and Cardiovascular Outcomes in Patients With Atrial Fibrillation and End-Stage Renal Disease.
    J Am Coll Cardiol. 2020;75:1299-1308.
    PubMed     Abstract available


  14. DRIGGIN E, Madhavan MV, Bikdeli B, Chuich T, et al
    Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the Coronavirus Disease 2019 (COVID-19) Pandemic.
    J Am Coll Cardiol. 2020 Mar 18. pii: S0735-1097(20)34637.
    PubMed     Abstract available


  15. CHENG EP, Yeo I, Kim LK, Lerman BB, et al
    Reply: Early Mortality Following Catheter Ablation of Atrial Fibrillation.
    J Am Coll Cardiol. 2020;75:1245-1247.
    PubMed    


  16. REN JF, Chen S, Callans DJ, Jiang C, et al
    Role of Intracardiac Echocardiography for Catheter Ablation of Atrial Fibrillation: Reduction of Complications and Mortality.
    J Am Coll Cardiol. 2020;75:1244-1245.
    PubMed    


  17. BOLLMANN A, Konig S, Basedow F, Hindricks G, et al
    Early Mortality After Catheter Ablation of Atrial Fibrillation.
    J Am Coll Cardiol. 2020;75:1243-1244.
    PubMed    


  18. COOPER LT JR
    Ventricular Arrhythmias and Sudden Cardiac Death in Lymphocytic Myocarditis.
    J Am Coll Cardiol. 2020;75:1058-1060.
    PubMed    


  19. PERETTO G, Sala S, Rizzo S, Palmisano A, et al
    Ventricular Arrhythmias in Myocarditis: Characterization and Relationships With Myocardial Inflammation.
    J Am Coll Cardiol. 2020;75:1046-1057.
    PubMed     Abstract available


    February 2020
  20. SIONTIS KC, Checkole S, Yao X, Gersh BJ, et al
    Do Observational Studies Agree With Randomized Trials?: Evaluation of Oral Anticoagulants in Atrial Fibrillation.
    J Am Coll Cardiol. 2020;75:562-563.
    PubMed    


    January 2020
  21. WALD R, Dorian P, Harel Z
    Benefits and Risks of Anticoagulation in Dialysis Patients With Nonvalvular Atrial Fibrillation: Navigating Through Darkness.
    J Am Coll Cardiol. 2020;75:286-288.
    PubMed    


  22. KUNO T, Takagi H, Ando T, Sugiyama T, et al
    Oral Anticoagulation for Patients With Atrial Fibrillation on Long-Term Hemodialysis.
    J Am Coll Cardiol. 2020;75:273-285.
    PubMed     Abstract available


  23. STEG PG, Ducrocq G, Bhatt DL, Hohnloser SH, et al
    Dabigatran Dual Therapy Versus Warfarin Triple Therapy Post PCI in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2020;75:238-240.
    PubMed    


  24. COHEN A
    Is Persistent Isolation of the LAA Necessary to Achieve Higher Success Rates in Atrial Fibrillation?
    J Am Coll Cardiol. 2020;75:128-129.
    PubMed    


  25. REDDY VY
    Reply: Common Carotid Artery Filter to Prevent Stroke in Atrial Fibrillation: A Neurologist's and Neuroradiologist's Perspective.
    J Am Coll Cardiol. 2020;75:127-128.
    PubMed    


  26. PAPANAGIOTOU P, Tsivgoulis G
    Common Carotid Artery Filter to Prevent Stroke in Atrial Fibrillation: A Neurologist's and Neuroradiologist's Perspective.
    J Am Coll Cardiol. 2020;75:126-127.
    PubMed    


    December 2019
  27. RUSSAK AJ, Johnson KW, Halperin JL, Percha B, et al
    Racial and Sex Differences in Stroke Risk in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2019;74:3069-3070.
    PubMed    


  28. ALKHOULI M, Friedman PA
    Ischemic Stroke Risk in Patients With Nonvalvular Atrial Fibrillation: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2019;74:3050-3065.
    PubMed     Abstract available


  29. GUE YX, Inoue N, Spinthakis N, Takei A, et al
    Thrombotic Profile and Oral Anticoagulation in Asian and Non-Asian Patients With Nonvalvular Atrial Fibrillation.
    J Am Coll Cardiol. 2019;74:2822-2824.
    PubMed    


  30. VOLGMAN AS, Bairey Merz CN, Benjamin EJ, Curtis AB, et al
    Sex and Race/Ethnicity Differences in Atrial Fibrillation.
    J Am Coll Cardiol. 2019;74:2812-2815.
    PubMed    


  31. GLOTZER TV
    The Naissance of Atrial Fibrillation.
    J Am Coll Cardiol. 2019;74:2782-2785.
    PubMed    


  32. DIEDERICHSEN SZ, Haugan KJ, Brandes A, Lanng MB, et al
    Natural History of Subclinical Atrial Fibrillation Detected by Implanted Loop Recorders.
    J Am Coll Cardiol. 2019;74:2771-2781.
    PubMed     Abstract available


    November 2019
  33. OBOKATA M, Reddy YNV, Shah SJ, Kaye DM, et al
    Effects of Interatrial Shunt on Pulmonary Vascular Function in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2019;74:2539-2550.
    PubMed     Abstract available


  34. QAMAR A, Antman EM, Giugliano RP
    Reply: Anticoagulants in Atrial Fibrillation and Liver Disease.
    J Am Coll Cardiol. 2019;74:2436-2437.
    PubMed    


  35. PIGNATELLI P, Pastori D, Violi F
    Anticoagulants in Atrial Fibrillation and Liver Disease.
    J Am Coll Cardiol. 2019;74:2436.
    PubMed    


  36. LIP GYH, Bhatt DL, Hohnloser SH, Kimura T, et al
    Dabigatran Dual Therapy Versus Warfarin Triple Therapy in Atrial Fibrillation Post-PCI: Time in Therapeutic Range.
    J Am Coll Cardiol. 2019;74:2431-2433.
    PubMed    


  37. CHOI EK, Lee SR, Oh S, Lip GYH, et al
    Reply: Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Liver Disease.
    J Am Coll Cardiol. 2019;74:2330-2331.
    PubMed    


  38. GUO W, Tian X, Qiu L, Li L, et al
    Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Liver Disease.
    J Am Coll Cardiol. 2019;74:2329-2330.
    PubMed    


  39. SHARMA SP, Turagam MK, Gopinathannair R, Reddy V, et al
    Direct Current Cardioversion of Atrial Fibrillation in Patients With Left Atrial Appendage Occlusion Devices.
    J Am Coll Cardiol. 2019;74:2267-2274.
    PubMed     Abstract available


  40. CALKINS H
    When it Comes to the Mortality Rates of Catheter Ablation of Atrial Fibrillation, Experience Matters.
    J Am Coll Cardiol. 2019;74:2265-2266.
    PubMed    


  41. CHENG EP, Liu CF, Yeo I, Markowitz SM, et al
    Risk of Mortality Following Catheter Ablation of Atrial Fibrillation.
    J Am Coll Cardiol. 2019;74:2254-2264.
    PubMed     Abstract available


    October 2019
  42. KUMAR S, Lim E, Covic A, Verhamme P, et al
    Anticoagulation in Concomitant Chronic Kidney Disease and Atrial Fibrillation: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2019;74:2204-2215.
    PubMed     Abstract available


  43. GAGE BF
    Warfarin-Induced Fractures in Atrial Fibrillation?
    J Am Coll Cardiol. 2019;74:2159-2161.
    PubMed    


  44. BINDING C, Bjerring Olesen J, Abrahamsen B, Staerk L, et al
    Osteoporotic Fractures in Patients With Atrial Fibrillation Treated With Conventional Versus Direct Anticoagulants.
    J Am Coll Cardiol. 2019;74:2150-2158.
    PubMed     Abstract available


  45. CHAMBERLAIN AM
    Secondhand Smoke and Atrial Fibrillation: Importance of Managing Modifiable Risk Factors.
    J Am Coll Cardiol. 2019;74:1665-1666.
    PubMed    


  46. GROH CA, Vittinghoff E, Benjamin EJ, Dupuis J, et al
    Childhood Tobacco Smoke Exposure and Risk of Atrial Fibrillation in Adulthood.
    J Am Coll Cardiol. 2019;74:1658-1664.
    PubMed     Abstract available


    September 2019
  47. SARDANA M, Hsue PY, Tseng ZH, Vittinghoff E, et al
    Human Immunodeficiency Virus Infection and Incident Atrial Fibrillation.
    J Am Coll Cardiol. 2019;74:1512-1514.
    PubMed    


  48. KOTTKAMP H
    On the Atrial Fibrillation Substrate: From the "Unknown Species" to Deeper Insights Into Pathophysiology.
    J Am Coll Cardiol. 2019;74:1348-1351.
    PubMed    


  49. HIRAM R, Naud P, Xiong F, Al-U'datt D, et al
    Right Atrial Mechanisms of Atrial Fibrillation in a Rat Model of Right Heart Disease.
    J Am Coll Cardiol. 2019;74:1332-1347.
    PubMed     Abstract available


    August 2019
  50. WANG A, Green JB, Halperin JL, Piccini JP Sr, et al
    Atrial Fibrillation and Diabetes Mellitus: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2019;74:1107-1115.
    PubMed     Abstract available


  51. DI BIASE L, Mohanty S, Trivedi C, Romero J, et al
    Stroke Risk in Patients With Atrial Fibrillation Undergoing Electrical Isolation of the Left Atrial Appendage.
    J Am Coll Cardiol. 2019;74:1019-1028.
    PubMed     Abstract available


  52. RODES-CABAU J, Ellenbogen KA, Krahn AD, Latib A, et al
    Management of Conduction Disturbances Associated With Transcatheter Aortic Valve Replacement: JACC Scientific Expert Panel.
    J Am Coll Cardiol. 2019;74:1086-1106.
    PubMed     Abstract available


  53. DESHAIES C, Hamilton RM, Shohoudi A, Trottier H, et al
    Thromboembolic Risk After Atriopulmonary, Lateral Tunnel, and Extracardiac Conduit Fontan Surgery.
    J Am Coll Cardiol. 2019;74:1071-1081.
    PubMed     Abstract available


  54. GUO Y, Wang H, Zhang H, Liu T, et al
    Mobile Health Technology for Atrial Fibrillation Screening Using Photoplethysmography-Based Smart Devices: The HUAWEI Heart study.
    J Am Coll Cardiol. 2019 Aug 22. pii: S0735-1097(19)36365.
    PubMed     Abstract available


  55. MIYOSHI T, Maeno Y, Hamasaki T, Inamura N, et al
    Antenatal Therapy for Fetal Supraventricular Tachyarrhythmias: Multicenter Trial.
    J Am Coll Cardiol. 2019;74:874-885.
    PubMed     Abstract available


  56. ZOGHBI WA
    Should Left Atrial Size Influence the Decision to Intervene in Degenerative Mitral Regurgitation?
    J Am Coll Cardiol. 2019;74:871-873.
    PubMed    


  57. ESSAYAGH B, Antoine C, Benfari G, Messika-Zeitoun D, et al
    Prognostic Implications of Left Atrial Enlargement in Degenerative Mitral Regurgitation.
    J Am Coll Cardiol. 2019;74:858-870.
    PubMed     Abstract available


  58. NESTELBERGER T, Boeddinghaus J, Wussler D, Twerenbold R, et al
    Predicting Major Adverse Events in Patients With Acute Myocardial Infarction.
    J Am Coll Cardiol. 2019;74:842-854.
    PubMed     Abstract available


    July 2019
  59. CHOI EK, Lee SR
    DOACs in Patients With Atrial Fibrillation and Liver Disease: Time to Expand the Safety Zone?
    J Am Coll Cardiol. 2019;74:190-192.
    PubMed    


  60. QAMAR A, Antman EM, Ruff CT, Nordio F, et al
    Edoxaban Versus Warfarin in Patients With Atrial Fibrillation and History of Liver Disease.
    J Am Coll Cardiol. 2019;74:179-189.
    PubMed     Abstract available


  61. CAPODANNO D, Huber K, Mehran R, Lip GYH, et al
    Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2019;74:83-99.
    PubMed     Abstract available


  62. HUANG B
    Atrial Fibrillation Accompanying Mitral Stenosis: Another Fortress Captured by Direct Oral Anticoagulants?
    J Am Coll Cardiol. 2019;73:3361-3362.
    PubMed    


  63. GIANCATERINO S, Hsu JC
    Valvular Atrial Fibrillation: A Confusing and Obsolete Definition.
    J Am Coll Cardiol. 2019;73:3360-3361.
    PubMed    


  64. LEE SR, Lee HJ, Choi EK, Han KD, et al
    Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Liver Disease.
    J Am Coll Cardiol. 2019;73:3295-3308.
    PubMed     Abstract available


  65. KIM JY, Kim SH
    Reply: Off-Label Use of Direct Oral Anticoagulants in Patients With Mitral Stenosis.
    J Am Coll Cardiol. 2019;73:3362-3363.
    PubMed    


  66. ZHOU Z
    Efficacy and Safety of Direct Oral Anticoagulants in Patients With Mitral Stenosis.
    J Am Coll Cardiol. 2019;73:3362.
    PubMed    


    June 2019
  67. VERHEUGT FWA, Ten Berg JM, Storey RF, Cuisset T, et al
    Antithrombotic Agents: From Aspirin to DOACs in Coronary Artery Disease and in Atrial Fibrillation (Part I).
    J Am Coll Cardiol. 2019 Jun 27. pii: S0735-1097(19)35400.
    PubMed     Abstract available


  68. GOLD MR, Koerber SM
    Electrocardiogram in Cardiac Resynchronization Therapy: Is Non-Left Bundle Branch Block an Oversimplification?
    J Am Coll Cardiol. 2019;73:3100-3101.
    PubMed    


  69. EL-AM EA, Dispenzieri A, Grogan M, Nkomo VT, et al
    Reply: Cardiac Amyloidosis, Atrial Arrhythmias, Thrombus, and Stroke: A Vexing Problem.
    J Am Coll Cardiol. 2019;73:2911-2913.
    PubMed    


  70. RUSSO D, Limite LR, Arcari L, Autore C, et al
    Predicting the Unpredictable: How to Score the Risk of Stroke in Cardiac Amyloidosis?
    J Am Coll Cardiol. 2019;73:2910-2911.
    PubMed    


  71. CSECS I, Merkely B, Wilson BD
    Cardiac Amyloidosis and Electrical Cardioversion: Is the Thrombus There or Not?
    J Am Coll Cardiol. 2019;73:2909-2910.
    PubMed    


  72. DEFILIPPI C, Seliger S, Latta F, Peters M, et al
    High-Sensitivity Cardiac Troponin Assays Potentially Differentiate Acute From Chronic Myocardial Injury.
    J Am Coll Cardiol. 2019;73:2904-2905.
    PubMed    


    May 2019
  73. FAUCHIER L, Cinaud A, Brigadeau F, Lepillier A, et al
    Major Adverse Events With Percutaneous Left Atrial Appendage Closure in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2019;73:2638-2640.
    PubMed    


  74. BIRGERSDOTTER-GREEN U, Eskander MA
    Delayed Atrioventricular Block Following Transcatheter Aortic Valve Replacement: Risk Stratification or Crystal Ball?
    J Am Coll Cardiol. 2019;73:2548-2549.
    PubMed    


  75. REAM K, Sandhu A, Valle J, Weber R, et al
    Ambulatory Rhythm Monitoring to Detect Late High-Grade Atrioventricular Block Following Transcatheter Aortic Valve Replacement.
    J Am Coll Cardiol. 2019;73:2538-2547.
    PubMed     Abstract available


  76. ARIGA R, Tunnicliffe EM, Manohar SG, Mahmod M, et al
    Identification of Myocardial Disarray in Patients With Hypertrophic Cardiomyopathy and Ventricular Arrhythmias.
    J Am Coll Cardiol. 2019;73:2493-2502.
    PubMed     Abstract available


  77. MCKENNA WJ, Moon JC, Sulaiman A
    Understanding the Myocardial Architecture of Hypertrophic Cardiomyopathy for Clinical Care.
    J Am Coll Cardiol. 2019;73:2503-2505.
    PubMed    


  78. CRAWFORD TC
    Pacemaker Mortality After Surgical Ablation for Atrial Fibrillation: What Is Success and Failure?
    J Am Coll Cardiol. 2019;73:2436-2438.
    PubMed    


  79. DEROSE JJ JR, Mancini DM, Chang HL, Argenziano M, et al
    Pacemaker Implantation After Mitral Valve Surgery With Atrial Fibrillation Ablation.
    J Am Coll Cardiol. 2019;73:2427-2435.
    PubMed     Abstract available


  80. DEFERM S, Bertrand PB, Verbrugge FH, Verhaert D, et al
    Atrial Functional Mitral Regurgitation: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2019;73:2465-2476.
    PubMed     Abstract available


  81. SHINNAWI R, Shaheen N, Huber I, Shiti A, et al
    Modeling Reentry in the Short QT Syndrome With Human-Induced Pluripotent Stem Cell-Derived Cardiac Cell Sheets.
    J Am Coll Cardiol. 2019;73:2310-2324.
    PubMed     Abstract available


  82. HULOT JS
    Modeling Cardiac Arrhythmias With Organoids.
    J Am Coll Cardiol. 2019;73:2325-2327.
    PubMed    


  83. HUIZAR JF, Ellenbogen KA, Tan AY, Kaszala K, et al
    Arrhythmia-Induced Cardiomyopathy: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2019;73:2328-2344.
    PubMed     Abstract available


  84. REDDY VY, Neuzil P, de Potter T, van der Heyden J, et al
    A Percutaneous Permanent Carotid Filter for Stroke Prevention in Atrial Fibrillation: The CAPTURE Trial.
    J Am Coll Cardiol. 2019 May 8. pii: S0735-1097(19)35006.
    PubMed     Abstract available


    April 2019
  85. DE FERRARI GM, Dusi V, Ruffinazzi M, Gionti V, et al
    Physical Inactivity Is a Risk Factor for Primary Ventricular Fibrillation.
    J Am Coll Cardiol. 2019;73:2117-2118.
    PubMed    


  86. REDDY VY, Neuzil P, Koruth JS, Petru J, et al
    Pulsed Field Ablation for Pulmonary Vein Isolation in Atrial Fibrillation.
    J Am Coll Cardiol. 2019 Apr 29. pii: S0735-1097(19)34933.
    PubMed     Abstract available


  87. FRIEDMAN DJ, Pokorney SD, Khanna R, Goldstein L, et al
    Catheter Ablation of Atrial Fibrillation With and Without On-Site Cardiothoracic Surgery.
    J Am Coll Cardiol. 2019 Apr 29. pii: S0735-1097(19)33808.
    PubMed    


  88. PIERONI M, Notarstefano P, Bolognese L
    Brugada Syndrome in the Young and in the Adult: A Tale of 2 Diseases?
    J Am Coll Cardiol. 2019;73:1766-1768.
    PubMed    


  89. MAZZANTI A, Ovics P, Shauer A, Mameli S, et al
    Unexpected Risk Profile of a Large Pediatric Population With Brugada Syndrome.
    J Am Coll Cardiol. 2019;73:1868-1869.
    PubMed    


  90. MICHOWITZ Y, Milman A, Andorin A, Sarquella-Brugada G, et al
    Characterization and Management of Arrhythmic Events in Young Patients With Brugada Syndrome.
    J Am Coll Cardiol. 2019;73:1756-1765.
    PubMed     Abstract available


  91. ECKHARDT LL, Kalscheur MM
    Replacing Hardware With "Viralware".
    J Am Coll Cardiol. 2019;73:1688-1690.
    PubMed    


  92. DAWKINS JF, Hu YF, Valle J, Sanchez L, et al
    Antegrade Conduction Rescues Right Ventricular Pacing-Induced Cardiomyopathy in Complete Heart Block.
    J Am Coll Cardiol. 2019;73:1673-1687.
    PubMed     Abstract available


  93. STEVENSON WG, Tedrow UB, Reddy V, AbdelWahab A, et al
    Infusion Needle Radiofrequency Ablation for Treatment of Refractory Ventricular Arrhythmias.
    J Am Coll Cardiol. 2019;73:1413-1425.
    PubMed     Abstract available


  94. SHAH KS, Held EP
    Utilizing Biomarkers to Refine Risk Prediction in Atrial Fibrillation: A Step Toward Precision Medicine.
    J Am Coll Cardiol. 2019;73:1411-1412.
    PubMed    


  95. RAVASSA S, Ballesteros G, Lopez B, Ramos P, et al
    Combination of Circulating Type I Collagen-Related Biomarkers Is Associated With Atrial Fibrillation.
    J Am Coll Cardiol. 2019;73:1398-1410.
    PubMed     Abstract available


  96. HSIA HH, Xiong N
    Infusion Needle Ablation Catheter: An Evolution of Needs.
    J Am Coll Cardiol. 2019;73:1426-1429.
    PubMed    


  97. DEZORZI C, Boyle B, Qazi A, Luthra K, et al
    Administrative Billing Codes for Identifying Patients With Cardiac Arrest.
    J Am Coll Cardiol. 2019;73:1598-1600.
    PubMed    


    March 2019
  98. PIERONI M, Notarstefano P, Oliva A, Santangeli P, et al
    Reply: Myocardial Inflammation in Brugada Syndrome.
    J Am Coll Cardiol. 2019;73:1370.
    PubMed    


  99. MILES C, Asimaki A, Behr ER, Sheppard MN, et al
    Myocardial Inflammation in Brugada Syndrome.
    J Am Coll Cardiol. 2019;73:1369-1370.
    PubMed    


  100. MOSARLA RC, Vaduganathan M, Qamar A, Moslehi J, et al
    Anticoagulation Strategies in Patients With Cancer: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2019;73:1336-1349.
    PubMed     Abstract available


  101. JUNEJO RT, Braz ID, Lucas SJE, van Lieshout JJ, et al
    Impaired Cerebrovascular Reactivity in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2019;73:1230-1232.
    PubMed    


  102. GIUGLIANO RP, O'Gara PT
    DOACs in Patients With Mitral Stenosis and Atrial Fibrillation: Time for a Randomized Clinical Trial.
    J Am Coll Cardiol. 2019;73:1132-1134.
    PubMed    


  103. KIM JY, Kim SH, Myong JP, Kim YR, et al
    Outcomes of Direct Oral Anticoagulants in Patients With Mitral Stenosis.
    J Am Coll Cardiol. 2019;73:1123-1131.
    PubMed     Abstract available


  104. CONEN D, Rodondi N, Muller A, Beer JH, et al
    Relationships of Overt and Silent Brain Lesions With Cognitive Function in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2019;73:989-999.
    PubMed     Abstract available


  105. MCINTYRE WF, Healey JS, Devereaux PJ, Conen D, et al
    A Call for Randomized Trials of Oral Anticoagulation for Patients With Post-Operative Atrial Fibrillation.
    J Am Coll Cardiol. 2019;73:1105.
    PubMed    


  106. NARULA J, Ibanez B, Fuster V
    From Heart to Head, Thrombi to Emboli, and Inferences to Extrapolation.
    J Am Coll Cardiol. 2019;73:1000-1003.
    PubMed    


  107. VERHEUGT FWA
    Low Body Weight and Prescribing DOACs in Atrial Fibrillation.
    J Am Coll Cardiol. 2019;73:932-934.
    PubMed    


  108. LEE SR, Choi EK, Park CS, Han KD, et al
    Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Low Body Weight.
    J Am Coll Cardiol. 2019;73:919-931.
    PubMed     Abstract available


    February 2019
  109. GUGLIN M, Zucker MJ, Bazan VM, Bozkurt B, et al
    Venoarterial ECMO for Adults: JACC Scientific Expert Panel.
    J Am Coll Cardiol. 2019;73:698-716.
    PubMed     Abstract available


  110. DIENER HC, Hart RG, Koudstaal PJ, Lane DA, et al
    Atrial Fibrillation and Cognitive Function: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2019;73:612-619.
    PubMed     Abstract available


  111. ANDERSON KP
    Cardiac Amyloidosis and the Risks of Cardioversion.
    J Am Coll Cardiol. 2019;73:598-601.
    PubMed    


  112. EL-AM EA, Dispenzieri A, Melduni RM, Ammash NM, et al
    Direct Current Cardioversion of Atrial Arrhythmias in Adults With Cardiac Amyloidosis.
    J Am Coll Cardiol. 2019;73:589-597.
    PubMed     Abstract available


    January 2019
  113. BORGER MA, Mansour MC, Levine RA
    Atrial Fibrillation and Mitral Valve Prolapse: Time to Intervene?
    J Am Coll Cardiol. 2019;73:275-277.
    PubMed    


  114. GRIGIONI F, Benfari G, Vanoverschelde JL, Tribouilloy C, et al
    Long-Term Implications of Atrial Fibrillation in Patients With Degenerative Mitral Regurgitation.
    J Am Coll Cardiol. 2019;73:264-274.
    PubMed     Abstract available


  115. TURAGAM MK, Lakkireddy D
    Reply: Relevant Anatomic Determinants for Epicardial Left Atrial Appendage Exclusion.
    J Am Coll Cardiol. 2019;73:381.
    PubMed    


  116. PORTA-SANCHEZ A, Pizarro G, Salvador-Montanes O, Sanchez-Quintana D, et al
    Relevant Anatomic Determinants for Epicardial Left Atrial Appendage Exclusion.
    J Am Coll Cardiol. 2019;73:380-381.
    PubMed    


  117. JANUARY CT, Wann LS, Calkins H, Chen LY, et al
    2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Hea
    J Am Coll Cardiol. 2019 Jan 21. pii: S0735-1097(19)30209.
    PubMed    


  118. BONNY A, Ngantcha M, Scholtz W, Chin A, et al
    Cardiac Arrhythmias in Africa: Epidemiology, Management Challenges, and Perspectives.
    J Am Coll Cardiol. 2019;73:100-109.
    PubMed     Abstract available


  119. OVERTCHOUK P, Guedeney P, Rouanet S, Verhoye JP, et al
    Long-Term Mortality and Early Valve Dysfunction According to Anticoagulation Use: The FRANCE TAVI Registry.
    J Am Coll Cardiol. 2019;73:13-21.
    PubMed     Abstract available


    December 2018
  120. AUFFRET V, Martins RP, Daubert C, Leclercq C, et al
    Idiopathic/Iatrogenic Left Bundle Branch Block-Induced Reversible Left Ventricle Dysfunction: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2018;72:3177-3188.
    PubMed     Abstract available


  121. ARNOLD AD, Shun-Shin MJ, Keene D, Howard JP, et al
    His Resynchronization Versus Biventricular Pacing in Patients With Heart Failure and Left Bundle Branch Block.
    J Am Coll Cardiol. 2018;72:3112-3122.
    PubMed     Abstract available


  122. MILLER MA, Dukkipati SR, Turagam M, Liao SL, et al
    Arrhythmic Mitral Valve Prolapse: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2018;72.
    PubMed     Abstract available


  123. FAUCHIER L, Cinaud A, Brigadeau F, Lepillier A, et al
    Left Atrial Appendage Closure in Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:2806-2807.
    PubMed    


    November 2018
  124. LIN YC, Chien LN, Huang CY
    Reply: Optimal Dose of Rivaroxaban in Asians With Atrial Fibrillation: Further Studies Are Warranted.
    J Am Coll Cardiol. 2018;72:2682-2683.
    PubMed    


  125. HUANG Y, Mai L, Zhang Y, Cai X, et al
    Optimal Dose of Rivaroxaban in Asians With Atrial Fibrillation: Further Studies Are Warranted.
    J Am Coll Cardiol. 2018;72:2681-2682.
    PubMed    


  126. KIRCHHOF P, Bach M, Camm AJ
    Reply: Anticoagulants for Cardioembolism Prevention in Atrial Fibrillation Patients: Potential Bias From Real-World Studies.
    J Am Coll Cardiol. 2018;72:2546-2547.
    PubMed    


  127. LI HF, Hong Y
    Anticoagulants for Cardioembolism Prevention in Atrial Fibrillation Patients: Potential Bias From Real-World Studies.
    J Am Coll Cardiol. 2018;72:2545-2546.
    PubMed    


  128. JUNG H, Sung JH, Yang PS, Jang E, et al
    Stroke Risk Stratification for Atrial Fibrillation Patients With Hypertrophic Cardiomyopathy.
    J Am Coll Cardiol. 2018;72:2409-2411.
    PubMed    


  129. LINZ D, Brooks AG, Elliott AD, Kalman JM, et al
    Nightly Variation in Sleep Apnea Severity as Atrial Fibrillation Risk.
    J Am Coll Cardiol. 2018;72:2406-2407.
    PubMed    


    October 2018
  130. KUSUMOTO FM, Schoenfeld MH, Barrett C, Edgerton JR, et al
    2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guideli
    J Am Coll Cardiol. 2018 Oct 31. pii: S0735-1097(18)38984.
    PubMed    


  131. KUSUMOTO FM, Schoenfeld MH, Barrett C, Edgerton JR, et al
    2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart R
    J Am Coll Cardiol. 2018 Oct 31. pii: S0735-1097(18)38985.
    PubMed    


  132. SLOTWINER DJ, Raitt MH, Del-Carpio Munoz F, Mulpuru SK, et al
    Impact of Physiologic Pacing Versus Right Ventricular Pacing Among Patients With Left Ventricular Ejection Fraction Greater Than 35%: A Systematic Review for the 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia
    J Am Coll Cardiol. 2018 Oct 31. pii: S0735-1097(18)38988.
    PubMed     Abstract available


  133. CURTIS AB, Khan HA
    Should All Atrial Fibrillation Be Considered a Life-Long Problem Requiring Prophylaxis Against Thromboembolism?
    J Am Coll Cardiol. 2018;72:2037-2039.
    PubMed    


  134. BUTT JH, Olesen JB, Havers-Borgersen E, Gundlund A, et al
    Risk of Thromboembolism Associated With Atrial Fibrillation Following Noncardiac Surgery.
    J Am Coll Cardiol. 2018;72:2027-2036.
    PubMed     Abstract available


  135. JI-YOUNG LEE C, Torp-Pedersen C
    Reply: DOACs Versus Warfarin in Preventing Myocardial Infarction: Are the Benefits Worth the Price?
    J Am Coll Cardiol. 2018;72:2093-2094.
    PubMed    


  136. YE ZL, Guo WQ, Li L
    Non-VKA Oral Anticoagulant and Risk of Myocardial Infarction: Paradoxical Procoagulant Effect of Warfarin?
    J Am Coll Cardiol. 2018;72:2093.
    PubMed    


  137. ALOIA E
    DOACs Versus Warfarin in Preventing Myocardial Infarction: Are the Benefits Worth the Price?
    J Am Coll Cardiol. 2018;72:2092-2093.
    PubMed    


  138. CHEN ST, Melloni C
    Atrial Fibrillation in Cancer Patients: Recognizing Gaps in Care.
    J Am Coll Cardiol. 2018;72:1923-1925.
    PubMed    


  139. O'NEAL WT, Claxton JS, Sandesara PB, MacLehose RF, et al
    Provider Specialty, Anticoagulation, and Stroke Risk in Patients With Atrial Fibrillation and Cancer.
    J Am Coll Cardiol. 2018;72:1913-1922.
    PubMed     Abstract available


  140. KOTECHA D, Pollack CV Jr, De Caterina R, Renda G, et al
    Direct Oral Anticoagulants Halve Thromboembolic Events After Cardioversion of AF Compared With Warfarin.
    J Am Coll Cardiol. 2018;72:1984-1986.
    PubMed    


  141. SINDET-PEDERSEN C, Lamberts M, Staerk L, Nissen Bonde A, et al
    Combining Oral Anticoagulants With Platelet Inhibitors in Patients With Atrial Fibrillation and Coronary Disease.
    J Am Coll Cardiol. 2018;72:1790-1800.
    PubMed     Abstract available


    September 2018
  142. CORBALAN R, Nicolau JC, Lopez-Sendon J, Garcia-Castillo A, et al
    Edoxaban Versus Warfarin in Latin American Patients With Atrial Fibrillation: The ENGAGE AF-TIMI 48 Trial.
    J Am Coll Cardiol. 2018;72:1466-1475.
    PubMed     Abstract available


  143. BUMGARNER JM, Lambert CT, Tarakji KG
    Reply: The Smartwatch Will See You Now: Implications of Mass Screening for Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:1434-1435.
    PubMed    


  144. GIANCATERINO SK, Hsu JC
    The Smartwatch Will See You Now: Implications of Mass Screening for Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:1433-1434.
    PubMed    


  145. BONDE AN, Staerk L, Lee CJ, Vinding NE, et al
    Outcomes Among Patients With Atrial Fibrillation and Appropriate Anticoagulation Control.
    J Am Coll Cardiol. 2018;72:1357-1365.
    PubMed     Abstract available


  146. TURAGAM MK, Vuddanda V, Verberkmoes N, Ohtsuka T, et al
    Epicardial Left Atrial Appendage Exclusion Reduces Blood Pressure in Patients With Atrial Fibrillation and Hypertension.
    J Am Coll Cardiol. 2018;72:1346-1353.
    PubMed     Abstract available


  147. KIM D, Yang PS, Kim TH, Jang E, et al
    Ideal Blood Pressure in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:1233-1245.
    PubMed     Abstract available


  148. PHILLIPS RA, Arnold RM, Peterson LE
    Hypertension Guidelines: The Threads That Bind Them.
    J Am Coll Cardiol. 2018;72:1246-1251.
    PubMed    


    August 2018
  149. STEENSIG K, Olesen KKW, Thim T, Nielsen JC, et al
    Coronary artery disease is independent risk factor for stroke among patients with atrial fibrillation.
    J Am Coll Cardiol. 2018 Aug 23. pii: S0735-1097(18)36961.
    PubMed    


  150. LEE SR, Choi EK, Han KD, Jung JH, et al
    Edoxaban in Asian Patients With Atrial Fibrillation: Effectiveness and Safety.
    J Am Coll Cardiol. 2018;72:838-853.
    PubMed     Abstract available


  151. GANDJBAKHCH E, Redheuil A, Pousset F, Charron P, et al
    Clinical Diagnosis, Imaging, and Genetics of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2018;72:784-804.
    PubMed     Abstract available


  152. COOKE JP, Sukhovershin RA
    Novel Markers for Adverse Events in Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:734-737.
    PubMed    


  153. HOROWITZ JD, De Caterina R, Heresztyn T, Alexander JH, et al
    Asymmetric and Symmetric Dimethylarginine Predict Outcomes in Patients With Atrial Fibrillation: An ARISTOTLE Substudy.
    J Am Coll Cardiol. 2018;72:721-733.
    PubMed     Abstract available


  154. GUHA A, Derbala MH, Zhao Q, Wiczer TE, et al
    Ventricular Arrhythmias Following Ibrutinib Initiation for Lymphoid Malignancies.
    J Am Coll Cardiol. 2018;72:697-698.
    PubMed    


  155. ALBERT CM
    Ranolazine in Patients With Implantable Cardioverter-Defibrillators: Ready for Prime Time?
    J Am Coll Cardiol. 2018;72:646-649.
    PubMed    


    July 2018
  156. LIN YC, Chien SC, Hsieh YC, Shih CM, et al
    Effectiveness and Safety of Standard- and Low-Dose Rivaroxaban in Asians With Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:477-485.
    PubMed     Abstract available


  157. FAUCHIER L, Cinaud A, Brigadeau F, Lepillier A, et al
    Reply: Device-Related Thrombus After Percutaneous Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:474-475.
    PubMed    


  158. KEA B, Lin AL, Olshansky B, Malveau S, et al
    Stroke Prophylaxis After a New Emergency Department Diagnosis of Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:471-472.
    PubMed    


  159. RENDA G, De Caterina R
    Sex Implications in the Response to Anticoagulant Therapy in Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:283-286.
    PubMed    


  160. LAW SWY, Lau WCY, Wong ICK, Lip GYH, et al
    Sex-Based Differences in Outcomes of Oral Anticoagulation in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:271-282.
    PubMed     Abstract available


  161. KENT AP, Brueckmann M, Fraessdorf M, Connolly SJ, et al
    Concomitant Oral Anticoagulant and Nonsteroidal Anti-Inflammatory Drug Therapy in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:255-267.
    PubMed     Abstract available


  162. HEALEY JS
    Stroke Prevention in Atrial Fibrillation: What Is Real World, and What Do Real-World Data Reveal?
    J Am Coll Cardiol. 2018;72:154-155.
    PubMed    


  163. KIRCHHOF P, Radaideh G, Kim YH, Lanas F, et al
    Global Prospective Safety Analysis of Rivaroxaban.
    J Am Coll Cardiol. 2018;72:141-153.
    PubMed     Abstract available


  164. LEE CJ, Gerds TA, Carlson N, Bonde AN, et al
    Risk of Myocardial Infarction in Anticoagulated Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:17-26.
    PubMed     Abstract available


  165. LOPES RD, Rordorf R, De Ferrari GM, Leonardi S, et al
    Reply: Digoxin Use in Atrial Fibrillation: Minimizing and Refining its Use When Still Needed.
    J Am Coll Cardiol. 2018;72:125-126.
    PubMed    


  166. HOHNLOSER SH, Eikelboom JW
    Direct Oral Anticoagulants and Myocardial Infarction: The Dust Is Settling.
    J Am Coll Cardiol. 2018;72:27-28.
    PubMed    


    June 2018
  167. TURAGAM MK, Velagapudi P, Kar S, Holmes D, et al
    Cardiovascular Therapies Targeting Left Atrial Appendage.
    J Am Coll Cardiol. 2018 Jun 25. pii: S0735-1097(18)35139.
    PubMed     Abstract available


  168. ALKHOULI M, Noseworthy PA, Rihal CS, Holmes DR Jr, et al
    Stroke Prevention in Nonvalvular Atrial Fibrillation: A Stakeholder Perspective.
    J Am Coll Cardiol. 2018;71:2790-2801.
    PubMed     Abstract available


  169. MCCONNELL MV, Turakhia MP, Harrington RA, King AC, et al
    Mobile Health Advances in Physical Activity, Fitness, and Atrial Fibrillation: Moving Hearts.
    J Am Coll Cardiol. 2018;71:2691-2701.
    PubMed     Abstract available


  170. GLOTZER TV
    The Cacophony of Silent Atrial Fibrillation.
    J Am Coll Cardiol. 2018;71:2612-2615.
    PubMed    


  171. WONG JA, Conen D, Van Gelder IC, McIntyre WF, et al
    Progression of Device-Detected Subclinical Atrial Fibrillation and the Risk of Heart Failure.
    J Am Coll Cardiol. 2018;71:2603-2611.
    PubMed     Abstract available


    May 2018
  172. MELA T
    Smartwatches in the Fight Against Atrial Fibrillation: The Little Watch That Could.
    J Am Coll Cardiol. 2018;71:2389-2391.
    PubMed    


  173. SZE E, Daubert JP
    Reply: Early Cardiac Resynchronization Therapy for Left Bundle Branch Block-Associated Cardiomyopathies.
    J Am Coll Cardiol. 2018;71:1945-1946.
    PubMed    


  174. WANG NC, Adelstein EC, Singh M, Voigt AH, et al
    Left Bundle Branch Block-Associated Cardiomyopathies and Early Cardiac Resynchronization Therapy: Conceptualizing a Tailored Approach.
    J Am Coll Cardiol. 2018;71:1943-1944.
    PubMed    


  175. CHATZIDOU S, Kontogiannis C, Tsilimigras DI, Georgiopoulos G, et al
    Propranolol Versus Metoprolol for Treatment of Electrical Storm in Patients With Implantable Cardioverter-Defibrillator.
    J Am Coll Cardiol. 2018;71:1897-1906.
    PubMed     Abstract available


    April 2018
  176. GRACE AA, Matthews GDK
    Phenotypic Landscape and Risk Management in Long QT Syndrome: Nudging Forward.
    J Am Coll Cardiol. 2018;71:1672-1675.
    PubMed    


  177. MAZZANTI A, Maragna R, Vacanti G, Monteforte N, et al
    Interplay Between Genetic Substrate, QTc Duration, and Arrhythmia Risk in Patients With Long QT Syndrome.
    J Am Coll Cardiol. 2018;71:1663-1671.
    PubMed     Abstract available


  178. FAUCHIER L, Cinaud A, Brigadeau F, Lepillier A, et al
    Device-Related Thrombosis After Percutaneous Left Atrial Appendage Occlusion for Atrial Fibrillation.
    J Am Coll Cardiol. 2018;71:1528-1536.
    PubMed     Abstract available


  179. YU L, Zhou L, Meng G, Jiang H, et al
    Reply: Optogenetic Neuromodulation of Stellate Ganglia for Patients With Ventricular Arrhythmias, Atrial Fibrillation, Angina, and Takotsubo?
    J Am Coll Cardiol. 2018;71:1496-1497.
    PubMed    


  180. MADIAS JE
    Optogenetic Neuromodulation of Stellate Ganglia for Patients With Ventricular Arrhythmias, Atrial Fibrillation, Angina, and Takotsubo?
    J Am Coll Cardiol. 2018;71:1495-1496.
    PubMed    


    March 2018
  181. TAYAL B, Gorcsan J 3rd, Bax JJ, Risum N, et al
    Cardiac Resynchronization Therapy in Patients With Heart Failure and Narrow QRS Complexes.
    J Am Coll Cardiol. 2018;71:1325-1333.
    PubMed     Abstract available


  182. PRABHU S, Kistler PM
    Reply: Beyond Pulmonary Vein Isolation During Catheter Ablation in Atrial Fibrillation and Systolic Dysfunction.
    J Am Coll Cardiol. 2018;71:1293-1294.
    PubMed    


  183. ALDAAS OM, Padwal J, Hsu JC
    Beyond Pulmonary Vein Isolation During Catheter Ablation in Atrial Fibrillation and Systolic Dysfunction.
    J Am Coll Cardiol. 2018;71:1292-1293.
    PubMed    


  184. TURAKHIA MP
    Digoxin in Atrial Fibrillation?: Leave it Out of the Medicine Cabinet.
    J Am Coll Cardiol. 2018;71:1075-1077.
    PubMed    


  185. LOPES RD, Rordorf R, De Ferrari GM, Leonardi S, et al
    Digoxin and Mortality in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2018;71:1063-1074.
    PubMed     Abstract available


  186. MOGENSEN UM, Kober L, McMurray JJV
    Reply: Time for an "Atrial-Watchful" Approach for Heart Failure Patients With a Cardiac Implantable Electronic Device.
    J Am Coll Cardiol. 2018;71:1188-1189.
    PubMed    


  187. CANEPA M, Bertero E, Brunelli C, Ameri P, et al
    Time for an "Atrial-Watchful" Approach for Heart Failure Patients With a Cardiac Implantable Electronic Device.
    J Am Coll Cardiol. 2018;71:1187-1188.
    PubMed    


  188. BUMGARNER JM, Lambert CT, Hussein AA, Cantillon DJ, et al
    Automated Atrial Fibrillation Detection Algorithm Using Smartwatch Technology.
    J Am Coll Cardiol. 2018 Mar 7. pii: S0735-1097(18)33486.
    PubMed     Abstract available


  189. KING JB, Marrouche N
    Reply: What Is the Biological Relationship Between Left Atrial Fibrosis and Stroke in Atrial Fibrillation?
    J Am Coll Cardiol. 2018;71:1054-1056.
    PubMed    


  190. REN JF, Callans DJ, Marchlinski FE
    What Is the Biological Relationship Between Left Atrial Fibrosis and Stroke in Atrial Fibrillation?
    J Am Coll Cardiol. 2018;71:1053-1054.
    PubMed    


    February 2018
  191. VERMA A, Bhatt DL, Verma S
    Long-Term Outcomes of Post-Operative Atrial Fibrillation: Guilty as Charged.
    J Am Coll Cardiol. 2018;71:749-751.
    PubMed    


  192. KOSMIDOU I, Chen S, Kappetein AP, Serruys PW, et al
    New-Onset Atrial Fibrillation After PCI or CABG for Left Main Disease: The EXCEL Trial.
    J Am Coll Cardiol. 2018;71:739-748.
    PubMed     Abstract available


  193. FERREIRA JP, Girerd N, Gregson J, Latar I, et al
    Stroke Risk in Patients With Reduced Ejection Fraction After Myocardial Infarction Without Atrial Fibrillation.
    J Am Coll Cardiol. 2018;71:727-735.
    PubMed     Abstract available


  194. PASTORI D, Nocella C, Farcomeni A, Bartimoccia S, et al
    Reply: LDL-Cholesterol and Atherosclerotic Cardiovascular Disease: Innocent Bystander or Essential Ingredient?
    J Am Coll Cardiol. 2018;71:706-707.
    PubMed    


  195. EGOM EE
    LDL-Cholesterol and Atherosclerotic Cardiovascular Disease: Innocent Bystander or Essential Ingredient.
    J Am Coll Cardiol. 2018;71:705-706.
    PubMed    


    January 2018
  196. LINDE C, Braunschweig F
    Cardiomyopathy and Left Bundle Branch Block: A Farewell to Drugs?
    J Am Coll Cardiol. 2018;71:318-320.
    PubMed    


  197. SZE E, Samad Z, Dunning A, Campbell KB, et al
    Impaired Recovery of Left Ventricular Function in Patients With Cardiomyopathy and Left Bundle Branch Block.
    J Am Coll Cardiol. 2018;71:306-317.
    PubMed     Abstract available


  198. SHIN JI, Luo S, Alexander GC, Inker LA, et al
    Direct Oral Anticoagulants and Risk of Acute Kidney Injury in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2018;71:251-252.
    PubMed    


  199. GONZALEZ CORCIA MC, Sieira J, Pappaert G, de Asmundis C, et al
    Implantable Cardioverter-Defibrillators in Children and Adolescents With Brugada Syndrome.
    J Am Coll Cardiol. 2018;71:148-157.
    PubMed     Abstract available


  200. GAGE BF
    Stroke Prediction Rules in Atrial Fibrillation.
    J Am Coll Cardiol. 2018;71:133-134.
    PubMed    


  201. CHAO TF, Lip GYH, Liu CJ, Lin YJ, et al
    Relationship of Aging and Incident Comorbidities to Stroke Risk in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2018;71:122-132.
    PubMed     Abstract available


    December 2017
  202. KABIR RA, Doytchinova A, Liu X, Adams D, et al
    Crescendo Skin Sympathetic Nerve Activity and Ventricular Arrhythmia.
    J Am Coll Cardiol. 2017;70:3201-3202.
    PubMed    


  203. BRUGADA P
    Short QT Syndrome and Hydroquinidine: Rare Diseases and Unavailable Drugs.
    J Am Coll Cardiol. 2017;70:3016-3017.
    PubMed    


  204. MAZZANTI A, Maragna R, Vacanti G, Kostopoulou A, et al
    Hydroquinidine Prevents Life-Threatening Arrhythmic Events in Patients With Short QT Syndrome.
    J Am Coll Cardiol. 2017;70:3010-3015.
    PubMed     Abstract available


  205. REDDY VY, Doshi SK, Kar S, Gibson DN, et al
    5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials.
    J Am Coll Cardiol. 2017;70:2964-2975.
    PubMed     Abstract available


  206. KHAIRY P
    Reply: Atrial Fibrillation: The Next Epidemic for Patients With Congenital Heart Disease.
    J Am Coll Cardiol. 2017;70:2950-2951.
    PubMed    


  207. TEUWEN CP, de Groot NMS
    Atrial Fibrillation: The Next Epidemic for Patients With Congenital Heart Disease.
    J Am Coll Cardiol. 2017;70:2949-2950.
    PubMed    


  208. SANDERS P, Elliott AD, Linz D
    Upstream Targets to Treat Atrial Fibrillation.
    J Am Coll Cardiol. 2017;70:2906-2908.
    PubMed    


  209. TAKEMOTO Y, Ramirez RJ, Kaur K, Salvador-Montanes O, et al
    Eplerenone Reduces Atrial Fibrillation Burden Without Preventing Atrial Electrical Remodeling.
    J Am Coll Cardiol. 2017;70:2893-2905.
    PubMed     Abstract available


  210. DUKKIPATI SR, Koruth JS, Choudry S, Miller MA, et al
    Catheter Ablation of Ventricular Tachycardia in Structural Heart Disease: Indications, Strategies, and Outcomes-Part II.
    J Am Coll Cardiol. 2017;70:2924-2941.
    PubMed     Abstract available


  211. DUKKIPATI SR, Choudry S, Koruth JS, Miller MA, et al
    Catheter Ablation of Ventricular Tachycardia in Structurally Normal Hearts: Indications, Strategies, and Outcomes-Part I.
    J Am Coll Cardiol. 2017;70:2909-2923.
    PubMed     Abstract available


  212. YU L, Zhou L, Cao G, Po SS, et al
    Optogenetic Modulation of Cardiac Sympathetic Nerve Activity to Prevent Ventricular Arrhythmias.
    J Am Coll Cardiol. 2017;70:2778-2790.
    PubMed     Abstract available


    November 2017
  213. YAO X, Shah ND, Sangaralingham LR, Gersh BJ, et al
    Reply: NOAC Dosing in Patients With Atrial Fibrillation and Renal Dysfunction.
    J Am Coll Cardiol. 2017;70:2734-2735.
    PubMed    


  214. SHROFF GR
    NOAC Dosing in Atrial Fibrillation and Renal Dysfunction: What Measure Are You Using?
    J Am Coll Cardiol. 2017;70:2733-2734.
    PubMed    


  215. HUSSAIN A, Jain SK, Wang NC
    Improved Outcomes With Cardiology Care in Newly Diagnosed Atrial Fibrillation: Is Tachycardia-Induced Cardiomyopathy Underestimated?
    J Am Coll Cardiol. 2017;70:2730.
    PubMed    


  216. PERINO AC, Turakhia MP
    Reply: Improved Outcomes With Cardiology Care in Newly Diagnosed Atrial Fibrillation: Is Tachycardia-Induced Cardiomyopathy Underestimated?
    J Am Coll Cardiol. 2017;70:2730-2731.
    PubMed    


  217. WALSH M, Connolly SJ
    Another Dimension of Safety in the Prescription of Anticoagulants for Nonvalvular Atrial Fibrillation.
    J Am Coll Cardiol. 2017;70:2633-2635.
    PubMed    


  218. YAO X, Tangri N, Gersh BJ, Sangaralingham LR, et al
    Renal Outcomes in Anticoagulated Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2017;70:2621-2632.
    PubMed     Abstract available


  219. MOGENSEN UM, Jhund PS, Abraham WT, Desai AS, et al
    Type of Atrial Fibrillation and Outcomes in Patients With Heart Failure and Reduced Ejection Fraction.
    J Am Coll Cardiol. 2017;70:2490-2500.
    PubMed     Abstract available


    October 2017
  220. ABU-OMAR Y, Thorpe BS, Freeman C, Mills C, et al
    Recovery of Left Atrial Contractile Function After Maze Surgery in Persistent Longstanding Atrial Fibrillation.
    J Am Coll Cardiol. 2017;70:2309-2311.
    PubMed    


  221. AL-KHATIB SM, Stevenson WG, Ackerman MJ, Bryant WJ, et al
    2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the
    J Am Coll Cardiol. 2017 Oct 25. pii: S0735-1097(17)41306.
    PubMed    


  222. MILAN D
    The Com-PLEC-sity of Atrial Fibrillation Genetics.
    J Am Coll Cardiol. 2017;70:2169-2170.
    PubMed    


  223. THOROLFSDOTTIR RB, Sveinbjornsson G, Sulem P, Helgadottir A, et al
    A Missense Variant in PLEC Increases Risk of Atrial Fibrillation.
    J Am Coll Cardiol. 2017;70:2157-2168.
    PubMed     Abstract available


  224. KUSUMOTO FM, Bailey KR, Chaouki AS, Deshmukh AJ, et al
    Systematic Review for the 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical P
    J Am Coll Cardiol. 2017 Oct 24. pii: S0735-1097(17)41304.
    PubMed     Abstract available


  225. AL-KHATIB SM, Stevenson WG, Ackerman MJ, Bryant WJ, et al
    2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice
    J Am Coll Cardiol. 2017 Oct 24. pii: S0735-1097(17)41305.
    PubMed    


  226. LAVIE CJ, Pandey A, Lau DH, Alpert MA, et al
    Obesity and Atrial Fibrillation Prevalence, Pathogenesis, and Prognosis: Effects of Weight Loss and Exercise.
    J Am Coll Cardiol. 2017;70:2022-2035.
    PubMed     Abstract available


  227. HERNANDEZ-OJEDA J, Arbelo E, Borras R, Berne P, et al
    Patients With Brugada Syndrome and Implanted Cardioverter-Defibrillators: Long-Term Follow-Up.
    J Am Coll Cardiol. 2017;70:1991-2002.
    PubMed     Abstract available


  228. BARON-ESQUIVIAS G, Morillo CA, Moya-Mitjans A, Martinez-Alday J, et al
    Dual-Chamber Pacing With Closed Loop Stimulation in Recurrent Reflex Vasovagal Syncope: The SPAIN Study.
    J Am Coll Cardiol. 2017;70:1720-1728.
    PubMed     Abstract available


    September 2017
  229. PAQUETTE M, Riou Franca L, Teutsch C, Diener HC, et al
    Persistence With Dabigatran Therapy at 2 Years in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2017;70:1573-1583.
    PubMed     Abstract available


  230. NICHOL G, Sayre MR, Guerra F, Poole J, et al
    Defibrillation for Ventricular Fibrillation: A Shocking Update.
    J Am Coll Cardiol. 2017;70:1496-1509.
    PubMed     Abstract available


  231. PASTORI D, Nocella C, Farcomeni A, Bartimoccia S, et al
    Relationship of PCSK9 and Urinary Thromboxane Excretion to Cardiovascular Events in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2017;70:1455-1462.
    PubMed     Abstract available


  232. BOCCHI EA, Bestetti RB, Scanavacca MI, Cunha Neto E, et al
    Chronic Chagas Heart Disease Management: From Etiology to Cardiomyopathy Treatment.
    J Am Coll Cardiol. 2017;70:1510-1524.
    PubMed     Abstract available


  233. DEBATY G, Labarere J, Frascone RJ, Wayne MA, et al
    Long-Term Prognostic Value of Gasping During Out-of-Hospital Cardiac Arrest.
    J Am Coll Cardiol. 2017;70:1467-1476.
    PubMed     Abstract available


  234. GURBEL PA, Navarese EP, Tantry US
    Exploration of PCSK9 as a Cardiovascular Risk Factor: Is There a Link to the Platelet?
    J Am Coll Cardiol. 2017;70:1463-1466.
    PubMed    


  235. BLOOMGARDEN ZT, Kosiborod MN, Handelsman Y
    Concomitant Diabetes and Atrial Fibrillation: No Sugarcoating the Bittersweet Reality.
    J Am Coll Cardiol. 2017;70:1336-1338.
    PubMed    


  236. ECHOUFFO-TCHEUGUI JB, Shrader P, Thomas L, Gersh BJ, et al
    Care Patterns and Outcomes in Atrial Fibrillation Patients With and Without Diabetes: ORBIT-AF Registry.
    J Am Coll Cardiol. 2017;70:1325-1335.
    PubMed     Abstract available


  237. NAZARIAN S, Zghaib T
    Is Atrial Fibrillation a Necessary Component of the Thrombogenic Atrium?
    J Am Coll Cardiol. 2017;70:1322-1324.
    PubMed    


  238. KING JB, Azadani PN, Suksaranjit P, Bress AP, et al
    Left Atrial Fibrosis and Risk of Cerebrovascular and Cardiovascular Events in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2017;70:1311-1321.
    PubMed     Abstract available


  239. ESCANDE W, Boveda S, Defaye P, Leclercq C, et al
    Outcomes in Guideline-Based Versus Off-Guideline Primary Prevention Implantable Cardioverter-Defibrillator Recipients.
    J Am Coll Cardiol. 2017;70:1302-1303.
    PubMed    


    August 2017
  240. DESIMONE CV, Graff-Radford J, El-Harasis MA, Rabinstein AA, et al
    Cerebral Amyloid Angiopathy: Diagnosis, Clinical Implications, and Management Strategies in Atrial Fibrillation.
    J Am Coll Cardiol. 2017;70:1173-1182.
    PubMed     Abstract available


  241. YANNOPOULOS D, Bartos JA, Raveendran G, Conterato M, et al
    Coronary Artery Disease in Patients With Out-of-Hospital Refractory Ventricular Fibrillation Cardiac Arrest.
    J Am Coll Cardiol. 2017;70:1109-1117.
    PubMed     Abstract available


  242. WAZNI O, Chung MK
    Catheter Ablation for Rate Controlled Atrial Fibrillation: New Horizon in Heart Failure Treatment.
    J Am Coll Cardiol. 2017 Aug 22. pii: S0735-1097(17)39348.
    PubMed    


  243. PRABHU S, Taylor AJ, Costello BT, Kaye DM, et al
    Catheter Ablation Versus Medical Rate control in Atrial Fibrillation and Systolic Dysfunction (CAMERA-MRI).
    J Am Coll Cardiol. 2017 Aug 22. pii: S0735-1097(17)39349.
    PubMed     Abstract available


  244. SILKA MJ, Bar-Cohen Y
    Prevalence of Atrial Fibrillation and Permanent Atrial Arrhythmias in Congenital Heart Disease: Sequel or Series?
    J Am Coll Cardiol. 2017;70:866-868.
    PubMed    


  245. LABOMBARDA F, Hamilton R, Shohoudi A, Aboulhosn J, et al
    Increasing Prevalence of Atrial Fibrillation and Permanent Atrial Arrhythmias in Congenital Heart Disease.
    J Am Coll Cardiol. 2017;70:857-865.
    PubMed     Abstract available


  246. POOLE JE, Prutkin JM
    Subcutaneous Implantable Cardioverter-Defibrillator Finding a Place in Sudden Cardiac Death Prevention: Emerging or Emerged?
    J Am Coll Cardiol. 2017;70:842-844.
    PubMed    


  247. BOERSMA L, Barr C, Knops R, Theuns D, et al
    Implant and Midterm Outcomes of the Subcutaneous Implantable Cardioverter-Defibrillator Registry: The EFFORTLESS Study.
    J Am Coll Cardiol. 2017;70:830-841.
    PubMed     Abstract available


  248. IWASAWA J, Koruth JS, Petru J, Dujka L, et al
    Temperature-Controlled Radiofrequency Ablation for Pulmonary Vein Isolation in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2017;70:542-553.
    PubMed     Abstract available


    July 2017
  249. SCHWARTZ PJ, Dagradi F, Castelletti S
    Evolution in Managing Long QT Syndrome: From Registries to Centers of Excellence.
    J Am Coll Cardiol. 2017;70:463-465.
    PubMed    


  250. ROHATGI RK, Sugrue A, Bos JM, Cannon BC, et al
    Contemporary Outcomes in Patients With Long QT Syndrome.
    J Am Coll Cardiol. 2017;70:453-462.
    PubMed     Abstract available


  251. SEKI A, Ishikawa T, Daumy X, Mishima H, et al
    Progressive Atrial Conduction Defects Associated With Bone Malformation Caused by a Connexin-45 Mutation.
    J Am Coll Cardiol. 2017;70:358-370.
    PubMed     Abstract available


  252. EPPINGA RN, Hartman MHT, Verweij N, van der Harst JJ, et al
    Refining Thromboembolic Risk in the General Population.
    J Am Coll Cardiol. 2017;70:403-404.
    PubMed    


  253. WHANG W
    Opportunities to Improve Outcomes in Atrial Fibrillation: Provider Specialty and Beyond.
    J Am Coll Cardiol. 2017;70:87-88.
    PubMed    


  254. PERINO AC, Fan J, Schmitt SK, Askari M, et al
    Treating Specialty and Outcomes in Newly Diagnosed Atrial Fibrillation: From the TREAT-AF Study.
    J Am Coll Cardiol. 2017;70:78-86.
    PubMed     Abstract available


    June 2017
  255. MILLER MA, Palaniswamy C, Dukkipati SR, Balulad S, et al
    Subcutaneous Implantable Cardioverter-Defibrillator Implantation Without Defibrillation Testing.
    J Am Coll Cardiol. 2017;69:3118-3119.
    PubMed    


  256. VASEGHI M, Barwad P, Malavassi Corrales FJ, Tandri H, et al
    Cardiac Sympathetic Denervation for Refractory Ventricular Arrhythmias.
    J Am Coll Cardiol. 2017;69:3070-3080.
    PubMed     Abstract available


  257. VIJAYARAMAN P, Bordachar P, Ellenbogen KA
    The Continued Search for Physiological Pacing: Where Are We Now?
    J Am Coll Cardiol. 2017;69:3099-3114.
    PubMed     Abstract available


  258. HALPERIN JL
    Preventing Myocardial Infarction in Patients With Atrial Fibrillation: Another Piece of the Puzzle.
    J Am Coll Cardiol. 2017;69:2910-2912.
    PubMed    


  259. LEE CJ, Pallisgaard JL, Olesen JB, Carlson N, et al
    Antithrombotic Therapy and First Myocardial Infarction in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2017;69:2901-2909.
    PubMed     Abstract available


  260. FILIPPATOS G, Farmakis D
    How to Use Beta-Blockers in Heart Failure With Reduced Ejection Fraction and Atrial Fibrillation.
    J Am Coll Cardiol. 2017;69:2897-2900.
    PubMed    


  261. YAO X, Shah ND, Sangaralingham LR, Gersh BJ, et al
    Non-Vitamin K Antagonist Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Renal Dysfunction.
    J Am Coll Cardiol. 2017;69:2779-2790.
    PubMed     Abstract available


    May 2017
  262. SOLOMON SD, Chatterjee NA
    Who Benefits From Implantable Cardioverter-Defibrillators?: Integrating Absolute, Proportional, and Competing Risk.
    J Am Coll Cardiol. 2017;69:2619-2621.
    PubMed    


  263. BILCHICK KC, Wang Y, Cheng A, Curtis JP, et al
    Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-Defibrillators.
    J Am Coll Cardiol. 2017;69:2606-2618.
    PubMed     Abstract available


  264. O'KEEFE JH, DiNicolantonio JJ
    Alcohol and Atrial Fibrillation: Mitigating the Risk.
    J Am Coll Cardiol. 2017;69:2578.
    PubMed    


  265. NATTEL S
    Atrial Fibrillation and Body Composition: Is it Fat or Lean That Ultimately Determines the Risk?
    J Am Coll Cardiol. 2017;69:2498-2501.
    PubMed    


  266. FENGER-GRON M, Overvad K, Tjonneland A, Frost L, et al
    Lean Body Mass Is the Predominant Anthropometric Risk Factor for Atrial Fibrillation.
    J Am Coll Cardiol. 2017;69:2488-2497.
    PubMed     Abstract available


  267. PETERSON ED, Pokorney SD
    New Treatment Options Fail to Close the Anticoagulation Gap in Atrial Fibrillation.
    J Am Coll Cardiol. 2017;69:2485-2487.
    PubMed    


  268. MARZEC LN, Wang J, Shah ND, Chan PS, et al
    Influence of Direct Oral Anticoagulants on Rates of Oral Anticoagulation for Atrial Fibrillation.
    J Am Coll Cardiol. 2017;69:2475-2484.
    PubMed     Abstract available


  269. DORKS M, Jobski K, Herget-Rosenthal S, Hoffmann F, et al
    Mortality and Acute Kidney Injury in Asians With Atrial Fibrillation Treated With Dabigatran or Warfarin.
    J Am Coll Cardiol. 2017;69:2471.
    PubMed    


  270. CHAN YH, Kuo CT
    Reply: Mortality and Acute Kidney Injury in Asians With Atrial Fibrillation Treated With Dabigatran or Warfarin.
    J Am Coll Cardiol. 2017;69:2471-2472.
    PubMed    


  271. MUELLER KAL, Heinzmann D, Klingel K, Fallier-Becker P, et al
    Histopathological and Immunological Characteristics of Tachycardia-Induced Cardiomyopathy.
    J Am Coll Cardiol. 2017;69:2160-2172.
    PubMed     Abstract available


  272. SANTANGELI P, Frankel DS, Tung R, Vaseghi M, et al
    Early Mortality After Catheter Ablation of Ventricular Tachycardia in Patients With Structural Heart Disease.
    J Am Coll Cardiol. 2017;69:2105-2115.
    PubMed     Abstract available


    April 2017
  273. HUCKER WJ, Hanley A, Ellinor PT
    Improving Atrial Fibrillation Therapy: Is There a Gene for That?
    J Am Coll Cardiol. 2017;69:2088-2095.
    PubMed     Abstract available


  274. SUNDARAM V, Sahadevan J, Waldo AL, Stukenborg GJ, et al
    Implantable Cardioverter-Defibrillators With Versus Without Resynchronization Therapy in Patients With a QRS Duration >180 ms.
    J Am Coll Cardiol. 2017;69:2026-2036.
    PubMed     Abstract available


  275. HOBBELT AH, Spronk HM, Crijns HJ, Ten Cate H, et al
    Prethrombotic State in Young Very Low-Risk Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2017;69:1990-1992.
    PubMed    


  276. DU X, Dong J, Ma C
    Is Atrial Fibrillation a Preventable Disease?
    J Am Coll Cardiol. 2017;69:1968-1982.
    PubMed     Abstract available


  277. LORBERBAUM T, Tatonetti NP
    Reply: Combination Therapy With Ceftriaxone and Lansoprazole, Acquired Long QT Syndrome and Torsades de Pointes Risk.
    J Am Coll Cardiol. 2017;69:1877-1878.
    PubMed    


  278. LAZZERINI PE, Bertolozzi I, Rossi M, Capecchi PL, et al
    Combination Therapy With Ceftriaxone and Lansoprazole, Acquired Long QT Syndrome, and Torsades de Pointes Risk.
    J Am Coll Cardiol. 2017;69:1876-1877.
    PubMed    


  279. SANTANGELI P, Rame JE, Birati EY, Marchlinski FE, et al
    Management of Ventricular Arrhythmias in Patients With Advanced Heart Failure.
    J Am Coll Cardiol. 2017;69:1842-1860.
    PubMed     Abstract available


  280. DRIESSEN AH, Berger WR, Chan Pin Yin DR, Piersma FR, et al
    Electrophysiologically Guided Thoracoscopic Surgery for Advanced Atrial Fibrillation: 5-Year Follow-up.
    J Am Coll Cardiol. 2017;69:1753-1754.
    PubMed    


  281. FLETCHER G
    Atrial Fibrillation: A Threat to the Failing Heart?
    J Am Coll Cardiol. 2017;69:1692-1693.
    PubMed    


  282. LUO N, Merrill P, Parikh KS, Whellan DJ, et al
    Exercise Training in Patients With Chronic Heart Failure and Atrial Fibrillation.
    J Am Coll Cardiol. 2017;69:1683-1691.
    PubMed     Abstract available


    March 2017
  283. DE CATERINA R, Renda G, Carnicelli AP, Nordio F, et al
    Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 Trial.
    J Am Coll Cardiol. 2017;69:1372-1382.
    PubMed     Abstract available


  284. ARBUSTINI E, Favalli V, Narula N, Serio A, et al
    Reply: A Distinct Cardiomyopathy: HCN4 Syndrome Comprising Myocardial Noncompaction, Bradycardia, Mitral Valve Defects, and Aortic Dilation.
    J Am Coll Cardiol. 2017;69:1210-1211.
    PubMed    


  285. SCHWEIZER PA, Koenen M, Katus HA, Thomas D, et al
    A Distinct Cardiomyopathy: HCN4 Syndrome Comprising Myocardial Noncompaction, Bradycardia, Mitral Valve Defects, and Aortic Dilation.
    J Am Coll Cardiol. 2017;69:1209-1210.
    PubMed    


    February 2017
  286. SHARMA S, Drezner JA, Baggish A, Papadakis M, et al
    International Recommendations for Electrocardiographic Interpretation in Athletes.
    J Am Coll Cardiol. 2017;69:1057-1075.
    PubMed     Abstract available


  287. HUISMAN MV, Rothman KJ, Paquette M, Teutsch C, et al
    The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2.
    J Am Coll Cardiol. 2017;69:777-785.
    PubMed     Abstract available


  288. VADUGANATHAN M, Patel RB, Michel A, Shah SJ, et al
    Mode of Death in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2017;69:556-569.
    PubMed     Abstract available


  289. VENLET J, Piers SR, Jongbloed JD, Androulakis AF, et al
    Isolated Subepicardial Right Ventricular Outflow Tract Scar in Athletes With Ventricular Tachycardia.
    J Am Coll Cardiol. 2017;69:497-507.
    PubMed     Abstract available


    January 2017
  290. VAL-BLASCO A, Piedras MJ, Ruiz-Hurtado G, Suarez N, et al
    Role of NOD1 in Heart Failure Progression via Regulation of Ca2+ Handling.
    J Am Coll Cardiol. 2017;69:423-433.
    PubMed     Abstract available


  291. SEITZ J, Bars C, Theodore G, Beurtheret S, et al
    AF Ablation Guided by Spatiotemporal Electrogram Dispersion Without Pulmonary Vein Isolation: A Wholly Patient-Tailored Approach.
    J Am Coll Cardiol. 2017;69:303-321.
    PubMed     Abstract available


  292. MADHAVAN M, Mulpuru SK, McLeod CJ, Cha YM, et al
    Advances and Future Directions in Cardiac Pacemakers: Part 2 of a 2-Part Series.
    J Am Coll Cardiol. 2017;69:211-235.
    PubMed     Abstract available


  293. MULPURU SK, Madhavan M, McLeod CJ, Cha YM, et al
    Cardiac Pacemakers: Function, Troubleshooting, and Management: Part 1 of a 2-Part Series.
    J Am Coll Cardiol. 2017;69:189-210.
    PubMed     Abstract available


    August 2016
  294. PARASHAR A, Sud K, Devgun J, Agarwal S, et al
    Feasibility of LAA Closure for Left Atrial Thrombus in Patients With Aortic Stenosis and AF.
    J Am Coll Cardiol. 2016;68:770-1.
    PubMed    


    May 2016
  295. SINNECKER D, Dommasch M, Steger A, Berkefeld A, et al
    Expiration-Triggered Sinus Arrhythmia Predicts Outcome in Survivors of Acute Myocardial Infarction.
    J Am Coll Cardiol. 2016;67:2213-20.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: